NASDAQ:FSTX

F-star Therapeutics News Headlines

$6.39

+0.03 (+0.47%)

(As of 06/24/2022 04:00 PM ET)

Add

Compare

Today's Range: $6.07
▼
$6.45
50-Day Range: $2.18
▼
$6.36
52-Week Range: $2.07
▼
$9.30

Volume: 1.22 million shs
Average Volume: 207,898 shs
Market Capitalization: $137.76 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $29.50

Get F-star Therapeutics News Delivered to You Automatically

FSTX Media Mentions By Week

FSTX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

FSTX
News Sentiment
▼
-0.25

0.38
▲
Average
Medical
News Sentiment

FSTX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

FSTX Articles
This Week
▼
12

1
▲
FSTX Articles
Average Week

FSTX Stock News Headlines Today

Source

Source	Headline
	F-star Therapeutics (NASDAQ:FSTX) Stock Rating Lowered by SVB Leerink marketbeat.com - June 23 at 4:32 PM
	F-star Therapeutics, Inc. (NASDAQ:FSTX) Receives Average Recommendation of "Moderate Buy" from Analysts marketbeat.com - June 23 at 4:13 PM
	F-star Therapeutics (NASDAQ:FSTX) Downgraded to "Neutral" at LADENBURG THALM/SH SH americanbankingnews.com - June 24 at 5:46 AM
	Shareholder Alert: Ademi LLP investigates whether F-star Therapeutics, Inc. has obtained a Fair Price in its transaction with invoX benzinga.com - June 23 at 6:26 PM
	FSTX Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of F-star Therapeutics, Inc. Is Fair to Shareholders apnews.com - June 23 at 6:26 PM
	F-star Therapeutics Shares Soar on Buyout Deal >FSTX marketwatch.com - June 23 at 6:26 PM
	invoX Pharma to Acquire F-star Therapeutics, Inc. a Pioneering Next Generation Bispecific Discovery Platform and Clinical Programs finance.yahoo.com - June 23 at 7:48 AM
	F-star Therapeutics, Inc. (NASDAQ:FSTX) Just Reported And Analysts Have Been Cutting Their Estimates finance.yahoo.com - May 14 at 3:29 PM
	F-star Therapeutics Inc. barrons.com - May 13 at 8:50 PM
	Fstar Therapeutics, Inc. (FSTX) Reports Q1 Loss, Tops Revenue Estimates nasdaq.com - May 10 at 12:46 PM
	F-star Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update finance.yahoo.com - May 10 at 12:46 PM

	F-star Therapeutics to Announce First Quarter Results and Host Conference Call on Tuesday, May 10th, 2022 finance.yahoo.com - May 2 at 10:24 AM
	F-star Therapeutics, Inc.: F-star Therapeutics Presents a Novel LAG-3 Reduction and Shedding Mechanism with FS118 at AACR 2022 finanznachrichten.de - April 8 at 10:35 AM
	F-star Therapeutics Presents a Novel LAG-3 Reduction and Shedding Mechanism with FS118 at AACR 2022 finance.yahoo.com - April 8 at 10:35 AM
	Strong week for F-star Therapeutics (NASDAQ:FSTX) shareholders doesn't alleviate pain of one-year loss finance.yahoo.com - March 21 at 8:15 PM
	HC Wainwright & Co. Initiates Coverage On F-star Therapeutics with Buy Rating, Announces Price Target of $35 benzinga.com - March 18 at 12:38 AM
	F-star Therapeutics, Inc. 2022 Q1 - Results - Earnings Call Presentation seekingalpha.com - March 14 at 10:55 AM
	F-star Therapeutics, Inc.: F-star Therapeutics Reports Full-Year 2021 Financial Results and Provides Corporate Update finanznachrichten.de - March 14 at 10:18 AM
	F-star Therapeutics Reports Full-Year 2021 Financial Results and Provides Corporate Update finance.yahoo.com - March 14 at 10:18 AM
	F-star Therapeutics to Present at the 32nd Annual Oppenheimer Healthcare Conference finance.yahoo.com - March 10 at 11:07 AM
	F-star Therapeutics to Host Fourth Quarter and Full-Year 2021 Financial Results Conference Call on March 14, 2022 finance.yahoo.com - March 2 at 8:13 AM
	F-star Therapeutics Appoints James Sandy as Chief Development Officer finance.yahoo.com - March 1 at 10:13 PM
	F-star Therapeutics gets US patent for antibody FS118 seekingalpha.com - January 22 at 6:31 PM
	F-star Therapeutics, Inc.: F-star Announces Issuance of U.S. Patent Protecting FS118, a Bispecific Antibody Targeting PD-L1 and LAG-3 finanznachrichten.de - January 20 at 10:48 AM
	F-star Announces Issuance of U.S. Patent Protecting FS118, a Bispecific Antibody Targeting PD-L1 and LAG-3 finance.yahoo.com - January 20 at 10:48 AM
	F-star Therapeutics Inc Shares Near 52-Week Low - Market Mover nasdaq.com - January 13 at 2:50 AM
	F-star Therapeutics to Participate in Upcoming Investor Conferences finance.yahoo.com - January 7 at 9:17 AM
	F-star Therapeutics : Merck KGaA Exercises Fourth Licensing Option In Immuno-Oncology Collaboration markets.businessinsider.com - January 5 at 1:38 PM
	F-star Therapeutics Announces Merck KGaA, Darmstadt, Germany Exercises a Fourth Licensing Option in Immuno-Oncology Collaboration finance.yahoo.com - January 5 at 8:38 AM
	Peering Into F-star Therapeutics Recent Short Interest msn.com - December 31 at 2:16 PM
	F-star Therapeutics to Present FS222 Trial-in-Progress Update at ESMO Immuno-Oncology Congress 2021 finance.yahoo.com - December 7 at 11:41 AM
	F-star Therapeutics to Host Virtual R&D Day on December 6, 2021 finance.yahoo.com - November 29 at 12:14 PM

	F-star Therapeutics (FSTX) Sees Hammer Chart Pattern: Time to Buy? nasdaq.com - November 15 at 8:21 AM
	F-star Therapeutics, Inc. : F-star Therapeutics to Present at The Society for Immunotherapy of Cancer (SITC) 2021 Conference markets.businessinsider.com - November 13 at 5:02 AM
	F-star Therapeutics to Present at The Society for Immunotherapy of Cancer (SITC) 2021 Conference finance.yahoo.com - November 12 at 12:33 PM
	Aerami Therapeutics Appoints Darlene Deptula-Hicks to its Board of Directors finance.yahoo.com - November 11 at 8:43 AM
	F-star Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update finance.yahoo.com - November 10 at 9:38 AM
	F-star Therapeutics to Announce Third Quarter Results and Host Conference Call on November 10, 2021 finance.yahoo.com - November 1 at 6:45 PM
	F-star Therapeutics Announces License Agreement with Janssen to Develop and Commercialize Multiple Next Generation Bispecific Antibody Therapeutics finance.yahoo.com - October 20 at 10:44 AM
	F-star Therapeutics to Present FS120 Phase 1 Trial-in-Progress Update at ESMO 2021 finance.yahoo.com - September 16 at 9:56 AM
	F-star Therapeutics to Present at H.C. Wainwright 23rd Annual Global Investment Conference finance.yahoo.com - September 9 at 9:35 AM
	F-star Therapeutics, Inc.: F-star Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Update finanznachrichten.de - August 12 at 5:56 PM
	F-star Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Update finance.yahoo.com - August 12 at 5:56 PM
	F-star Therapeutics, Inc.: F-star Therapeutics is Granted Composition of Matter Patent for its Novel Second Generation STING Agonist, SB 11285 finanznachrichten.de - August 10 at 12:56 PM
	Why F-star Therapeutics (FSTX) Might Surprise This Earnings Season nasdaq.com - August 10 at 12:56 PM
	F-star Therapeutics is Granted Composition of Matter Patent for its Novel Second Generation STING Agonist, SB 11285 finance.yahoo.com - August 10 at 12:56 PM
	F-star Therapeutics Announces Collaboration with MSD to Evaluate FS120 in Combination with KEYTRUDA finance.yahoo.com - August 4 at 12:38 PM
	F-star Therapeutics to Announce Second Quarter Results and Host Conference Call on August 12, 2021 finance.yahoo.com - August 2 at 1:30 PM
	F-star Therapeutics Provides Interim Update on SB 11285 First-In-Human Dose-Escalation Study in Patients with Advanced Solid Tumors finance.yahoo.com - July 26 at 12:12 PM
	Top Stocks To Watch This Week? 4 Biotech Stocks To Know nasdaq.com - July 15 at 11:41 PM
	Why F-Star Therapeutics Shares Are Trading Higher Today msn.com - July 8 at 3:00 PM
	IONTAS Collaboration With F-star Enters Oncology Phase 1 Clinical Trial ca.finance.yahoo.com - June 29 at 10:16 AM

Get F-star Therapeutics News Delivered to You Automatically

This page (NASDAQ:FSTX) was last updated on 6/24/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms